| 常用名 | CCF642 | CAS号 | 346640-08-2 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: CCF642 is a novel PDI-inhibiting compound with antimyeloma activity.The IC50 is 2.9 μmol/L.In vitro: CCF642 inhibit PDI reductase activity about 100-fold more potently than the structurally distinct established inhibitors PACMA 31 and LOC14. CCF642 causes acute ER stress in multiple myeloma cells accompanied by apoptosis-inducing calcium release.In vivo: CCF642 displayed potent efficacy in an aggressive syngeneic mouse model of multiple myeloma and prolonged the lifespan of C57BL/KaLwRij mice engrafted with 5TGM1-luc myeloma, an effect comparable to the first-line multiple myeloma therapeutic bortezomib. CCF642 can be given intravenously without injection reactions in mice with 10 mg/kg. 物理化学性质: CAS号:346640-08-2 常用中文名:CCF642 常用英文名:CCF 642 分子式:C15H10N2O4S3 分子量:378.446 密度:1.6±0.1 g/cm3 沸点:567.3±60.0 °C at 760 mmHg 熔点:N/A 闪点:296.9±32.9 °C 储存条件:-20℃ |